Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed director

Frazier Lifesciences Acquisition Corp Create: Alert

All | News | Filings
Date FiledTypeDescription
11/23/2022 8-K Appointed a new director
Docs: "Amended and Restated Memorandum and Articles of Association of the Surviving Company",
"Certificate of Incorporation of Frazier Lifesciences Acquisition Corporation",
"Bylaws of Frazier Lifesciences Acquisition Corporation",
"Warrant Assignment, Assumption and Amendment Agreement, between Continental Stock Transfer & Trust Company, NewAmsterdam Pharma Company B.V. and Frazier Lifesciences Acquisition Corporation",
"NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential Preferred Therapy for High Risk Cardiovascular Disease Patients"
11/15/2022 8-K Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits &...
Docs: "Frazier Lifesciences Acquisition Corporation shareholders approve business combination with NewAmsterdam Pharma Holding B.V. Menlo Park, Calif."
07/25/2022 8-K/A Quarterly results
07/25/2022 8-K Quarterly results
01/26/2022 8-K Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review &nbsp...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549"
05/24/2021 8-K Quarterly results
01/29/2021 8-K Quarterly results
12/17/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "Audited Balance Sheet as of December 11, 2020"
12/14/2020 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation ...
Docs: "Underwriting Agreement, by and among the Company and Credit Suisse Securities (USA) LLC as representative of the underwriters",
"Insurance 31.4 To the extent permitted by Applicable Law, the Company may pay, or agree to pay, a premium in respect of a contract insuring each of the following persons against risks determined by the directors, other than liability arising out of that person’ s own dishonesty: an existing or former director , Secretary or Officer or auditor of: the Company; a company which is or was a subsidiary of the Company; a company in which the Company has or had an interest ; and a trustee of an employee or retirement benefits scheme or other trust in which any of the persons referred to in paragraph is or was interested. 41 32. Notices Form of notices 32.1 Save where these Articles provide otherwise, any notice to be given to or by any person pursuant to these Articles shall be: in writing signed...",
"Warrant Agreement, between the Company and Continental Stock Transfer & Trust Company",
"Investment Management Trust Agreement, between the Company and Continental Stock Transfer & Trust Company",
"Registration and Shareholder Rights Agreement, by and among the Company, the Sponsor and the Holders signatory thereto",
"Private Placement Units Purchase Agreement, between the Company and the Sponsor",
"Administrative Services Agreement, between the Company and the Sponsor",
"Letter Agreement, by and among the Company, the Sponsor and each director and officer of the Company",
"Frazier Lifesciences Acquisition Corporation Announces Pricing of Upsized $120 Million Initial Public Offering"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy